A cost-effectiveness analysis comparing two different strategies in advanced maternal age: Combined first-trimester screening and maternal blood cell-free DNA testing
Objective: To estimate cost efficacy of first-trimester screening strategies based on nuchal translucency (NT) and maternal blood cell-free DNA (cfDNA) testing in women with advanced maternal age (AMA). Materials and methods: This was a retrospective population-based analysis of all pregnant women w...
Saved in:
Main Authors: | Min Pan (Author), Lv-Yin Huang (Author), Li Zhen (Author), Dong-Zhi Li (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2018-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Implementation of Maternal Blood Cell Free DNA Testing in Early Screening for Aneuploidies
by: María del Mar Gil, et al.
Published: (2019) -
Cell free fetal DNA testing in maternal blood of Romanian pregnant women
by: Viorica E Radoi, et al.
Published: (2015) -
Comparing the Efficiency of Three Protocols in Isolation of Cell Free Fetal DNA From Maternal Blood
by: Fatemeh Karami, et al.
Published: (2018) -
Current Perspectives of Prenatal Cell-free DNA Screening in Clinical Management of First-Trimester Septated Cystic Hygroma
by: Sherer DM, et al.
Published: (2022) -
Reviewing Accuracy of First Trimester Screening for Preeclampsia Using Maternal Factors and Biomarkers
by: Malone SL, et al.
Published: (2022)